Buck Wealth Strategies LLC Purchases 3,571 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Buck Wealth Strategies LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 29.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 15,747 shares of the healthcare conglomerate’s stock after purchasing an additional 3,571 shares during the period. Buck Wealth Strategies LLC’s holdings in UnitedHealth Group were worth $7,966,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Kathleen S. Wright Associates Inc. bought a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $27,000. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at about $30,000. West Financial Advisors LLC purchased a new stake in UnitedHealth Group in the 3rd quarter valued at about $32,000. RPg Family Wealth Advisory LLC bought a new position in shares of UnitedHealth Group in the third quarter valued at approximately $37,000. Finally, Friedenthal Financial bought a new position in UnitedHealth Group in the 3rd quarter valued at $51,000. 87.86% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of analysts recently issued reports on UNH shares. TD Cowen raised their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Stephens increased their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. Morgan Stanley dropped their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. Bank of America cut their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Finally, UBS Group reduced their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $629.32.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.33% of the stock is owned by insiders.

UnitedHealth Group Stock Down 1.1 %

Shares of UNH opened at $539.50 on Thursday. The firm has a market cap of $496.49 billion, a P/E ratio of 34.81, a P/E/G ratio of 1.48 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The stock has a 50 day simple moving average of $532.43 and a two-hundred day simple moving average of $564.77.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the previous year, the firm earned $5.83 EPS. The business’s quarterly revenue was up 6.8% on a year-over-year basis. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.63 earnings per share for the current fiscal year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.